Search Results 1031-1040 of 18065 for multiple%20sclerosis
The promise of plasma biomarkers to identify early pathology is growing rapidly (Palmqvist et al, 2020), however it is likely that multiple converging ...
ysiological assessment, Limb loss, Peripheral nerve injury, Multiple sclerosis, Muscular dystrophy, Neuromuscular disorder, Amyotrophic lateral sclerosis ...
Displaying 11-20 out of 20 doctors available ... sclerosis, Muscular dystrophy, Myopathy, Gait ... umor, Multiple sclerosis, Spinal cord injury ...
The purpose of this study is to identify patient factors that are associated with low-viability or low-dose out-of specification (OOS) in ciltacabtagene ...
Rochester, Minn. The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at ...
The purpose of this study is to determine the overall response rate (ORR) of utilizing elotuzumab, pomalidomide and dexamethasone in patients with multiple ...
... multiple. Cancer. Research shows new treatment could delay cancer progression in patients with high-risk smoldering multiple myeloma ... 20 · 21 · 22 · 23 · 24 ...
... multiple system atrophy (MSA), progressive ... Sclerosis (ALS) and Healthy Volunteers (HV) ... Sclerosis (ALS) and Healthy Volunteers (HV). Pagination ...
Being farsighted or having certain diseases — such as diabetes, multiple sclerosis ... 20, 2021. Print. Show references. Mian SI. Visual impairment in adults ...
The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.